Exclusive weekly insights for sharemarket success.
Tim Lincoln, Co-Founder and Chief Investment Officer, and Matt Swartz, Senior Portfolio Manager, will join the conversation once a month to share their passion and strategy for Lincoln Indicator’s Managed Funds, as well as their insights for investors.
In this week’s Taking Stock, Kien Trinh and Matthew Swartz analyse the rollercoaster week in the Australian stock market, exploring key stocks like annuity provider Challenger (CGF), and Cochlear’s (COH) guidance downgrade. They delve into factors driving market volatility, from bank valuation concerns to the impact of interest rate cuts on their profitability. Plus, they examine Step One’s (STP) underwhelming performance. Join us for another action packed episode.
Experience Stock Doctor yourself by taking a FREE trial today.
To discuss the future of your investments in detail, book in a free consultation with a Lincoln representative.
To discuss the future of your investments in detail, book in a free consultation with a Lincoln financial expert.